Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to approximately 20% at 1 year in patients with overweight or obesity without a weight loss plateau,

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending. But thus far, the data don’t show this.

Jonathan Van Ness is taking weight-loss medication to help him deal with a binge-eating disorder that, he says, caused him to rapidly gain and lose weight in the past. The hairstylist and Queer Eye alum,

Jonathan Van Ness has revealed he has been using weight-loss medication to get his binge-eating disorder under control. The Queer Eye star, who identifies as non-binary, has revealed that he tried weight-loss medication in a pill form two years ago but it didn't work for him.

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would drugmakers agree to reduce their prices right away?

Jonathan Van Ness is seen on the Netflix show, Queer Eye. He has, for the first time, spoken publicly about using weight loss drugs during his fitness journey.

"Yes, I am on a GLP-1 for a weight-loss medication,” the 'Queer Eye' star said Jonathan Van Ness is opening up on how weight-loss medication has been helping his binge-eating disorder. In a TikTok posted Wednesday,